Zacks: ICU Medical, Inc. (NASDAQ:ICUI) Given $175.67 Consensus Target Price by Analysts
Shares of ICU Medical, Inc. (NASDAQ:ICUI) have been assigned a consensus broker rating score of 2.20 (Buy) from the five brokers that provide coverage for the stock, Zacks Investment Research reports. Three analysts have rated the stock with a hold recommendation and two have issued a strong buy recommendation on the company. ICU Medical’s rating score has declined by 10% from 90 days ago as a result of various analysts’ ratings changes.
Brokers have set a one year consensus price target of $175.67 for the company and are forecasting that the company will post $0.56 EPS for the current quarter, according to Zacks. Zacks has also assigned ICU Medical an industry rank of 155 out of 265 based on the ratings given to its competitors.
Several analysts have commented on the company. Gabelli restated a “buy” rating on shares of ICU Medical in a report on Friday. BidaskClub cut ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 price target for the company in a report on Thursday, July 20th. Sidoti cut ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. Finally, Roth Capital cut ICU Medical from a “buy” rating to a “neutral” rating in a report on Thursday, May 11th. They noted that the move was a valuation call.
In other ICU Medical news, VP Alison D. Burcar sold 18,290 shares of ICU Medical stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $160.72, for a total value of $2,939,568.80. Following the completion of the sale, the vice president now owns 3,727 shares in the company, valued at approximately $599,003.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Vivek Jain sold 100,000 shares of ICU Medical stock in a transaction dated Tuesday, July 11th. The shares were sold at an average price of $170.80, for a total value of $17,080,000.00. Following the completion of the sale, the chairman now owns 110,925 shares of the company’s stock, valued at approximately $18,945,990. The disclosure for this sale can be found here. Insiders sold a total of 227,349 shares of company stock valued at $38,623,370 in the last 90 days. 15.90% of the stock is owned by company insiders.
Several hedge funds have recently modified their holdings of the company. Creative Planning boosted its stake in shares of ICU Medical by 315.6% in the first quarter. Creative Planning now owns 665 shares of the medical instruments supplier’s stock worth $102,000 after buying an additional 505 shares during the last quarter. Louisiana State Employees Retirement System boosted its stake in shares of ICU Medical by 1.7% in the first quarter. Louisiana State Employees Retirement System now owns 6,000 shares of the medical instruments supplier’s stock worth $916,000 after buying an additional 100 shares during the last quarter. Rice Hall James & Associates LLC boosted its stake in shares of ICU Medical by 2.7% in the first quarter. Rice Hall James & Associates LLC now owns 3,713 shares of the medical instruments supplier’s stock worth $567,000 after buying an additional 98 shares during the last quarter. State of Alaska Department of Revenue boosted its stake in shares of ICU Medical by 2.5% in the first quarter. State of Alaska Department of Revenue now owns 1,640 shares of the medical instruments supplier’s stock worth $250,000 after buying an additional 40 shares during the last quarter. Finally, Diversified Trust Co boosted its stake in shares of ICU Medical by 6.3% in the first quarter. Diversified Trust Co now owns 1,700 shares of the medical instruments supplier’s stock worth $260,000 after buying an additional 100 shares during the last quarter. Institutional investors and hedge funds own 77.10% of the company’s stock.
Shares of ICU Medical (NASDAQ ICUI) traded up 1.55% on Monday, reaching $167.45. 106,134 shares of the company’s stock traded hands. The stock’s 50-day moving average price is $171.98 and its 200-day moving average price is $159.30. ICU Medical has a 52 week low of $120.14 and a 52 week high of $176.50. The stock has a market capitalization of $3.32 billion, a price-to-earnings ratio of 67.06 and a beta of 0.37.
ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the consensus estimate of $0.58 by $0.06. The business had revenue of $331.51 million during the quarter, compared to analysts’ expectations of $318.30 million. ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The firm’s quarterly revenue was up 242.8% compared to the same quarter last year. During the same quarter last year, the firm earned $1.15 EPS. Equities analysts predict that ICU Medical will post $4.11 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This news story was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.watchlistnews.com/zacks-icu-medical-inc-nasdaqicui-given-175-67-consensus-target-price-by-analysts/1488073.html.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.